Fevertree Drinks (LON:FEVR – Get Rating)‘s stock had its “sector perform” rating restated by stock analysts at Royal Bank of Canada in a report released on Wednesday, MarketBeat Ratings reports. They currently have a GBX 1,600 ($19.99) price objective on the stock. Royal Bank of Canada’s target price indicates a potential downside of 6.76% from the stock’s current price.
A number of other analysts have also recently issued reports on the company. Citigroup restated a “neutral” rating and set a GBX 2,300 ($28.73) price objective on shares of Fevertree Drinks in a research report on Wednesday, January 26th. JPMorgan Chase & Co. raised shares of Fevertree Drinks to a “neutral” rating and lowered their price target for the company from GBX 2,000 ($24.98) to GBX 1,650 ($20.61) in a report on Friday, March 11th. Peel Hunt restated a “hold” rating and issued a GBX 1,900 ($23.74) price objective on shares of Fevertree Drinks in a research note on Tuesday, April 12th. Barclays decreased their target price on shares of Fevertree Drinks from GBX 3,200 ($39.98) to GBX 3,030 ($37.85) and set an “overweight” rating on the stock in a research report on Thursday, March 17th. Finally, Berenberg Bank reduced their target price on shares of Fevertree Drinks from GBX 2,600 ($32.48) to GBX 2,250 ($28.11) and set a “buy” rating on the stock in a research note on Thursday, March 24th. Eight research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, Fevertree Drinks currently has an average rating of “Hold” and a consensus target price of GBX 2,264.44 ($28.29).
Shares of FEVR opened at GBX 1,716 ($21.44) on Wednesday. The stock’s 50-day moving average price is GBX 1,762.60 and its 200 day moving average price is GBX 2,235.28. The company has a quick ratio of 4.58, a current ratio of 5.43 and a debt-to-equity ratio of 1.03. The firm has a market capitalization of £2.00 billion and a price-to-earnings ratio of 45.26. Fevertree Drinks has a 12-month low of GBX 1,456.09 ($18.19) and a 12-month high of GBX 2,871 ($35.87).
Fevertree Drinks Plc, together with its subsidiaries, develops and supplies premium mixer drinks in the United Kingdom, the United States, Europe, and internationally. The company's products include Indian tonic water, Mediterranean tonic water, elderflower tonic water, Clementine tonic water, ginger beer, ginger ale, and cola distillers.
- 3 Earnings Plays With Big Move Potential
- There Are Weeds In The Garden At Scotts Miracle-Gro
- It’s Time For FuboTV to Stand Out in the Sea of Streaming
- Landstar Systems Stock Can Bottom Down Here
- 3M Stock is Worth a Look Because of the Company it Keeps
Receive News & Ratings for Fevertree Drinks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fevertree Drinks and related companies with MarketBeat.com's FREE daily email newsletter.